Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502372 · ClinicalTrials.gov registry record · Phase 1
Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)
A Phase 1 study, sponsored by Central Arkansas Veterans Healthcare System.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00502372: Clinical Trial Phase 1 study, sponsored by Central Arkansas Veterans Healthcare System.
NCT00502372 is a Phase 1 study that was terminated before completion, run by Central Arkansas Veterans Healthcare System. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00502372, a Phase 1 study, was terminated before completion, sponsored by Central Arkansas Veterans Healthcare System.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The focus of this study is to look at the role of nutrition in the healing of pressure ulcers. The purpose of this study is to test whether the rate of healing of pressure ulcers is increased in those patients receiving a nutritional supplement of amino acids and the leucine metabolite, B-hydroxy-B-methylbutyrate is enhanced when compared to control patients receiving a supplement containing only one of the proteins in the experimental supplement
Primary Outcome
The PUSH tool measures the healing of a pressure ulcer by actually measuring the depth and width, in 2 dimensions, of a wound. A wound heals from the wound bed and closes from the inside to the outside if healthy pink granulation tissue can be seen. This tool contributes to the consistency of measurement of a healing wound.
Interventions
- DIETARY_SUPPLEMENT Juven
- DIETARY_SUPPLEMENT Nutritional Supplement/Amino acids and HMB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Why NCT00502372 stopped before completion
NCT00502372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Juven is the first listed.
NCT00502372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00502372 about?
NCT00502372 is a clinical study titled "Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)". The focus of this study is to look at the role of nutrition in the healing of pressure ulcers. The purpose of this study is to test whether the rate of healing of pressure ulcers is increased in those patients receiving a nutritional supplement of amino acids and the leucine metabolite, B-hydroxy-B-...
What is the current status of trial NCT00502372?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2008-12. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00502372?
The interventions under investigation include: Juven (DIETARY_SUPPLEMENT), Nutritional Supplement/Amino acids and HMB (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00502372?
This trial is sponsored by Central Arkansas Veterans Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00502372's enrollment target sits among peer trials
9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia